February 26, 2018 / 4:37 PM / 9 months ago

BRIEF-Shionogi Announces FDA NDA, EMA MAA Acceptances For Lusutrombopag

Feb 26 (Reuters) - Shionogi & Co Ltd:

* SHIONOGI ANNOUNCES FDA NEW DRUG APPLICATION (NDA) AND EMA MARKETING AUTHORIZATION APPLICATION (MAA) ACCEPTANCES FOR LUSUTROMBOPAG (S-888711)

* SHIONOGI & CO LTD - PRESCRIPTION DRUG USER FEE ACT DATE FOR AN FDA DECISION FOR LUSUTROMBOPAG IS AUGUST 26, 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below